83 results
S-3ASR
EX-5.1
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
of Directors’ interests or the power of interested Directors to vote), a quorum was present throughout, the requisite majority of Directors voted in favour
10-K
2023 FY
EX-10.12
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
that neither it, nor its Affiliates, develops, sells or manufactures tobacco products or makes the majority of its profits from the importation
10-K
2023 FY
EX-97.1
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
of independent directors, a majority of the independent directors serving on the Board, has made a determination that recoupment would be impracticable
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
immune cells. The majority of clinical studies involving treatment of patients with IL-12 were associated with severe systemic side effects mediated … chemotherapy enables 90% of adult patients to experience complete remission (“CR”). However, the majority of these remissions are not long-lasting
424B5
AUTL
Autolus Therapeutics plc
9 Feb 24
Prospectus supplement for primary offering
5:15pm
are incorporated under the laws of England and Wales and a majority of our outstanding securities are owned by non-U.S. residents. Under the rules of the SEC, we … (including ordinary shares represented by ADSs). Following this offering, these shareholders, together with BioNTech, will continue to control a majority
8-K
EX-5.1
p4d3m nf4uk
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
8-K
EX-1.1
g0pg3zrbjluy27fmi6yb
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
S-3ASR
EX-4.7
hhsuvki
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
4xcowo
7 Feb 24
Automatic shelf registration
10:00pm
S-3ASR
EX-5.1
l6z4ypwp7q6 o85
7 Feb 24
Automatic shelf registration
10:00pm
S-8
EX-5.1
i081 muc5ltf6mjq2wh
3 Nov 23
Registration of securities for employees
4:02pm
S-8
EX-5.1
yxm4 xhvaigmqbz
7 Aug 23
Registration of securities for employees
4:57pm
6-K
qs7i51ouz8klq8
6 Jul 23
Current report (foreign)
4:29pm
6-K
EX-1.1
7b1smyeri
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
6-K
EX-5.1
pli 5jhzq6
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
424B5
96nhj2jy23o7tc przhb
9 Dec 22
Prospectus supplement for primary offering
5:40pm
424B5
cbil792t76168
8 Dec 22
Prospectus supplement for primary offering
4:10pm
6-K
EX-1
wxfvsp1 qcjzc4
1 Jul 22
Current report (foreign)
5:15pm
6-K
u7il7reqz5c6ac 014t2
1 Jul 22
Current report (foreign)
5:15pm
424B3
zjhg1t h6nppo4c
18 May 22
Prospectus supplement
4:09pm